Subthalamic AAV-GAD (adeno-associated glutamic acid decarboxylase) injection improved motor signs in hemiparkinsonian macaques [98] and in individuals with PD with Hoehn and Yahr stage 3 or greater [99]. Here, GAD1 is linked to Parkinson disease.